[Treatment per os of disorders of erection].
Giuliano
F
F
Service d'Urologie, CHU de Bicêtre, Le Kremlin Bicêtre, France.
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use; D001058:Apomorphine / Q000008:administration & dosage / Q000627:therapeutic use; D006152:Cyclic GMP / Q000037:antagonists & inhibitors; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014196:Trazodone / Q000008:administration & dosage / Q000627:therapeutic use; D015016:Yohimbine / Q000008:administration & dosage / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D018687:Antidepressive Agents, Second-Generation; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D015016:Yohimbine; D000068677:Sildenafil Citrate; D006152:Cyclic GMP; D001058:Apomorphine; D014196:Trazodone; D010646:Phentolamine